| Brittany M Mcdonald, FNP | |
|
400 Patroon Creek Blvd Ste 1, Albany, NY 12206-5014 | |
| (518) 489-0044 | |
| (518) 489-3591 |
| Full Name | Brittany M Mcdonald |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 400 Patroon Creek Blvd Ste 1, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942764782 | NPI | - | NPPES |
| 05561582 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 343963 (New York) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 343963 (New York) | Primary |
| Entity Name | New York Oncology Hematology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609863448 PECOS PAC ID: 3072406222 Enrollment ID: O20040203000652 |
News Archive
A growing number of patient studies show that people who suffered post-traumatic stress disorder (PTSD) are at a higher risk of developing cardiovascular diseases, including stroke and heart attack. A new review article in American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines the recent scientific literature to explain how the two are linked.
A simple three-factor tool can help doctors estimate survival time in patients with long bone metastases (LBMs)- advanced cancer that has spread to the bones of the limbs, reports a study in the February 7, 2018, issue of The Journal of Bone & Joint Surgery.
Watson Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval of a novel oral contraceptive product – the first and only low dose oral contraceptive to combine 0.8 mg norethindrone and 0.025 mg ethinyl estradiol in chewable form, with four 75 mg ferrous fumarate (iron) placebo tablets. Taken orally, once daily, the product is proven effective in lowering the risk of pregnancy.
Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal of Parkinson's Disease.
› Verified 1 days ago
| Entity Name | Oldendorf Medical Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518107069 PECOS PAC ID: 3274684949 Enrollment ID: O20090622000002 |
News Archive
A growing number of patient studies show that people who suffered post-traumatic stress disorder (PTSD) are at a higher risk of developing cardiovascular diseases, including stroke and heart attack. A new review article in American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines the recent scientific literature to explain how the two are linked.
A simple three-factor tool can help doctors estimate survival time in patients with long bone metastases (LBMs)- advanced cancer that has spread to the bones of the limbs, reports a study in the February 7, 2018, issue of The Journal of Bone & Joint Surgery.
Watson Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval of a novel oral contraceptive product – the first and only low dose oral contraceptive to combine 0.8 mg norethindrone and 0.025 mg ethinyl estradiol in chewable form, with four 75 mg ferrous fumarate (iron) placebo tablets. Taken orally, once daily, the product is proven effective in lowering the risk of pregnancy.
Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal of Parkinson's Disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany M Mcdonald, FNP 449 Route 146 Ste 101, Halfmoon, NY 12065-3239 Ph: (518) 373-3800 | Brittany M Mcdonald, FNP 400 Patroon Creek Blvd Ste 1, Albany, NY 12206-5014 Ph: (518) 489-0044 |
News Archive
A growing number of patient studies show that people who suffered post-traumatic stress disorder (PTSD) are at a higher risk of developing cardiovascular diseases, including stroke and heart attack. A new review article in American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines the recent scientific literature to explain how the two are linked.
A simple three-factor tool can help doctors estimate survival time in patients with long bone metastases (LBMs)- advanced cancer that has spread to the bones of the limbs, reports a study in the February 7, 2018, issue of The Journal of Bone & Joint Surgery.
Watson Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval of a novel oral contraceptive product – the first and only low dose oral contraceptive to combine 0.8 mg norethindrone and 0.025 mg ethinyl estradiol in chewable form, with four 75 mg ferrous fumarate (iron) placebo tablets. Taken orally, once daily, the product is proven effective in lowering the risk of pregnancy.
Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal of Parkinson's Disease.
› Verified 1 days ago